Liver cancer is the third leading cause of cancer-related deaths worldwide, with
hepatocellular carcinoma (HCC) accounting for approximately 90% of primary liver cancers …

Background We sought to examine the prognostic impact of margin width at time of
hepatocellular carcinoma (HCC) resection relative to the alpha-feto protein tumor burden …

Background This study aimed to establish a simple prognostic scoring model based on
tumor burden score (TBS) and PIVKA‐II to predict long‐term outcomes of α‐fetoprotein …

Background AT-rich interaction domain 4B (ARID4B) is a transcriptional activator that
regulates the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in prostate cancer …

Background Salvage liver transplantation (SLT) is an effective treatment option for recurrent
hepatocellular carcinoma (rHCC) following primary curative treatment (CUR). However, its …

Background Patients with hepatocellular carcinoma (HCC) who undergo transarterial
chemoembolization (TACE) may have varied outcomes based on their liver function and …

Purpose Microvascular invasion (MVI) is a common complication of hepatocellular
carcinoma (HCC) surgery, which is an important predictor of reduced surgical prognosis …

Background Microvascular invasion (MVI) is a risk factor for postoperative recurrence of
hepatocellular carcinoma (HCC), even in early-stage HCC. In small HCC≤ 3 cm, treatment …

Objective We sought to develop Artificial Intelligence (AI) based models to predict non-
transplantable recurrence (NTR) of hepatocellular carcinoma (HCC) following hepatic …

The article discusses the treatment options for patients with single-nodule hepatocellular
carcinoma (HCC), including local ablation, surgical resection, and liver transplantation (LT) …